The chemopreventive effects of gliptins were also reported in colorectal cancer, about which DPP-IV inhibition has raised concerns because of its potential to enhance the intestinotrophic effects of GLP-2 [123,124]. This evidence concerns the gene DPP4 and colorectal cancer.